SCHEMBL29845293

SCHEMBL29845293

CN(C(=O)OC(C)(C)C)c1cc(B2OC(C)(C)C(C)(C)O2)ccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.44
BACE2 Q9Y5Z0 1/20 0.44
USP30 Q70CQ3 3/20 0.43
PRMT5 O14744 1/20 0.40
WDR77 Q9BQA1 1/20 0.40
AAK1 Q2M2I8 3/20 0.40
DGAT1 O75907 1/20 0.38
HIF1A Q16665 3/20 0.36
F2 P00734 1/20 0.32
F11 P03951 1/20 0.32
PRSS1 P07477 1/20 0.32
PRSS2 P07478 1/20 0.32
PRSS3 P35030 1/20 0.32
FFAR1 O14842 1/20 0.32
GSK3A P49840 1/20 0.31
GSK3B P49841 1/20 0.31
PAX8 Q06710 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25146980 1.00 BACE1 (0.44) BACE1BACE2USP30PRMT5WDR77
SCHEMBL21672314 0.89 BACE1 (0.49) BACE1BACE2USP30PRMT5WDR77
SCHEMBL26728111 0.85 BACE1 (0.42) BACE1BACE2USP30PRMT5WDR77
SCHEMBL4302491 0.83 BACE1 (0.43) BACE1BACE2USP30PRMT5WDR77
SCHEMBL21070780 0.82 BACE1 (0.42) BACE1BACE2USP30PRMT5WDR77
SCHEMBL3476749 0.82 LIPG (0.36) DGAT1HIF1AF2F11PRSS1
SCHEMBL17439308 0.82 DGAT1 (0.34) DGAT1HIF1AF2F11PRSS1
SCHEMBL1181140 0.82 DGAT1 (0.48) BACE1BACE2USP30PRMT5WDR77
SCHEMBL29827999 0.82 DGAT1 (0.48) BACE1BACE2USP30PRMT5WDR77
SCHEMBL26380196 0.81 BACE1 (0.40) BACE1BACE2USP30PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727920-A1 DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC (US) 2026-04-22 EP disclosed
WO-2024258919-A1 DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC (US) 2024-12-19 WO disclosed
EP-4444429-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC (US) 2024-10-16 EP disclosed
EP-4444430-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC (US) 2024-10-16 EP disclosed
EP-4301756-A1 HPK1 ANTAGONISTS AND USES THEREOF Nimbus Saturn, Inc. (US) 2024-01-10 EP disclosed
WO-2023108108-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC (US) 2023-06-15 WO disclosed
WO-2023108103-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC (US) 2023-06-15 WO disclosed
WO-2022187856-A1 HPK1 ANTAGONISTS AND USES THEREOF Nimbus Saturn, Inc. (US) 2022-09-09 WO disclosed